Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: The EPIC cohort

Neurology

Volumn 80, Issue 9, 2013, Pages 829-838

  Gallo, Valentina ^a,b   Wark, Petra A ^a   Jenab, Mazda ^d   Pearce, Neil ^c   Brayne, Carol ^e   Vermeulen, Roel ^f   Andersen, Peter M ^g   Hallmans, Goran ^g   Kyrozis, Andreas ^h   Vanacore, Nicola ⁱ   Vahdaninia, Mariam ^a,j   Grote, Verena ^k   Kaaks, Rudolf ^k   Mattiello, Amalia ^l   Bas Bueno De mesquita, H ^m,n   Peeters, Petra H ^o   Travis, Ruth C ^p   Petersson, Jesper ^q   Hansson, Oskar ^q   Arriola, Larraitz ^r   Martin, Juan Manuel Jimenez ^s   Tjønneland, Anne ^h   Halkjær, Jytte ^t   Agnoli, Claudia ^u   Sacerdote, Carlotta ^v,w   Bonet, Catalina ^x   Trichopoulou, Antonia ^t   Gavrila, Diana ^y,z   Overvad, Kim ^aa   Weiderpass, Elisabete ^ab,ac,ad   Palli, Domenico ^ae   Quirós, J Ramón ^af   Tumino, Rosario ^ag   Khaw, Kay Tee ^e   Wareham, Nicholas ^e   Barricante Gurrea, Aurelio ^z,ag   Fedirko, Veronika ^d   Ferrari, Pietro ^d   Clavel Chapelon, Françoise ^ah   Ruault, Marie Christine Boutron ^ah,aj   Boeing, Heiner ^ai   Vigl, Matthaeus ^ak   Middleton, Lefkos ^a   Riboli, Elio ^a   Vineis, Paolo ^a,w   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f Julius Center   (Netherlands)

^g UMEÅ UNIVERSITY   (Sweden)

^h UNIVERSITY OF ATHENS   (Greece)

ⁱ ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^j AVICENNA RESEARCH INSTITUTE   (Iran)

^k GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^l UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^m NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

ⁿ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^o Julius Center for Health Sciences and Primary Care   (Netherlands)

^p UNIVERSITY OF OXFORD   (United Kingdom)

^q LUND UNIVERSITY HOSPITAL   (Sweden)

^r Basque Government   (Spain)

^s ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^t DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^u NATIONAL CANCER INSTITUTE   (Italy)

^v Centre for Cancer Prevention (CPO Piemonte)   (Italy)

^w Human Genetics Foundation   (Italy)

^x CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^y DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^z CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^aa AARHUS UNIVERSITY HOSPITAL   (Denmark)

^ab UNIVERSITY OF TROMSØ   (Norway)

^ac Karlinska Institutet ^*

^ad KAROLINSKA INSTITUTE   (Sweden)

^ae CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^af Servicio de Investigación y Gestión del Conocimiento   (Spain)

^ag CIVILE M P AREZZO HOSPITAL   (Italy)

^ah INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ai INSTITUT GUSTAVE ROUSSY   (France)

^aj UNIVERSITÉ PARIS SACLAY   (France)

^ak GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; BODY MASS; COHORT ANALYSIS; DEATH; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; UNDERWEIGHT; WAIST CIRCUMFERENCE; ADIPOSE TISSUE; ANTHROPOMETRY; COMPARATIVE STUDY; HEALTH SURVEY; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; RISK; TIME;

ADIPOSE TISSUE; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTHROPOMETRY; BODY MASS INDEX; COHORT STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; TIME FACTORS;

MLCS; MLOWN;

EID: 84876332015     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182840689     Document Type: Article

References (34)

1. Armon C. Amyotrophic lateral sclerosis. In: Nelson LM, Tanner CM, Van Den Eeden SK, McGuire VM, editors. Neuroepidemiology. Oxford: Oxford University Press; 2004:162-187.
2. Armon C. Smoking may be considered an established risk factor for sporadic ALS. Neurology 2009;73:1693-1698.
3. Alonso A, Logroscino G, Hernan MA. Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and metaanalysis. J Neurol Neurosurg Psychiatry 2010;81:1249-1252.
4. Bastos AF, Orsini M, Machado D, et al. Amyotrophic lateral sclerosis: one or multiple causes? Neurol Int 2011;3:e4.
5. Sutedja NA, Fischer K, Veldink JH, et al. What we truly know about occupation as a risk factor for ALS: a critical and systematic review. Amyotroph Lateral Scler 2009;10:295-301.
6. Fang F, Quinlan P, Ye W, et al. Workplace exposures and the risk of amyotrophic lateral sclerosis. Environ Health Perspect 2009;117:1387-1392.
7. Vaisman N, Lusaus M, Nefussy B, et al. Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs? J Neurol Sci 2009;279:26-29.
8. Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology 1999;53:1059-1063.
9. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996;347:1425-1431.
10. Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis 2009;4:3.
11. Desport JC, Preux PM, Truong CT, Courat L, Vallat JM, Couratier P. Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:91-96.
12. Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr 1996;63:130-137.
13. Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 2011;10:75-82.
14. Scarmeas N, Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and varsity athletics in ALS. Neurology 2002;59:773-775.
15. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5: 1113-1124.
16. Haftenberger M, Lahmann PH, Panico S, et al. Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 2002; 5:1147-1162.
17. Gallo V, Bueno-De-Mesquita HB, Vermeulen R, et al. Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol 2009;65:378-385.
18. Harrell FE Jr, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst 1988;80:1198-1202.
19. Heinzl H, Kaider A. Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. Comput Methods Programs Biomed 1997;54:201-208.
20. Welborn TA, Dhaliwal SS. Preferred clinical measures of central obesity for predicting mortality. Eur J Clin Nutr 2007;61:1373-1379.
21. Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond) 2008;32:959-966.
22. Haslam DW, James WP. Obesity. Lancet 2005;366: 1197-1209.
23. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998;158:1855-1867.
24. Cepeda-Valery B, Pressman GS, Figueredo VM, Romero-Corral A. Impact of obesity on total and cardiovascular mortality: fat or fiction? Nat Rev Cardiol 2011;8:233-237.
25. Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008;359:2105-2120.
26. Desport JC, Preux PM, Magy L, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 2001;74:328-334.
27. Desport JC, Torny F, Lacoste M, Preux PM, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis 2005;2:202-207.
28. Funalot B, Desport JC, Sturtz F, Camu W, Couratier P. High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009;10:113-117.
29. Dupuis L, Oudart H, Rene F, Gonzalez De Aguilar JL, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA 2004;101:11159-11164.
30. Mattson MP, Cutler RG, Camandola S. Energy intake and amyotrophic lateral sclerosis. Neuromolecular Med 2007;9: 17-20.
31. Mattsson P, Lonnstedt I, Nygren I, Askmark H. Physical fitness, but not muscle strength, is a risk factor for death in amyotrophic lateral sclerosis at an early age. J Neurol Neurosurg Psychiatry 2012;83:390-394.
32. Sutedja NA, van der Schouw YT, Fischer K, et al. Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2011;82: 638-642.
33. Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve 2011;44:20-24.
34. Beghi E, Logroscino G, Micheli A, et al. Validity of hospital discharge diagnoses for the assessment of the prevalence and incidence of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2001;2:99-104.